Inventor · disambiguated record
Sangkon Oh
Also filed as: OH SANGKON
31 granted patents·18 pending applications·238 citations·filing 2004–2025
97Inventor score
Files withBAYLOR RES INSTITUTE21BAYLOR RES INST13BANCHEREAU JACQUES F5OH SANGKON5GORVEL JEAN-PIERRE1
Top patents by PatentIndex Score
49 records- 0197US8728481B2Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)BANCHEREAU JACQUES F·Filed 2012·Granted May 20, 2014·30 cites·9 claims
- 0297US8236934B2Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)BANCHEREAU JACQUES F·Filed 2008·Granted Aug 7, 2012·36 cites·44 claims
- 0396US12214034B2Vaccines against HPV and HPV-related diseasesBAYLOR RES INSTITUTE·Filed 2023·Granted Feb 4, 2025·1 cites·17 claims
- 0496US9453074B2Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)BAYLOR RES INST·Filed 2014·Granted Sep 27, 2016·31 cites·9 claims
- 0595US9102734B2Fusion proteins comprising antibody and HPV E6 and E7 antigensZURAWSKI GERARD·Filed 2010·Granted Aug 11, 2015·46 cites·13 claims
- 0693US12016915B2Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)BAYLOR RES INSTITUTE·Filed 2021·Granted Jun 25, 2024·1 cites·7 claims
- 0793US11806390B2Fusion proteins comprising an anti-CD40 antibody and cancer antigensBAYLOR RES INSTITUTE·Filed 2021·Granted Nov 7, 2023·2 cites·14 claims
- 0891US12186379B2Dendritic cell ASGPR targeting immunotherapeutics for multiple sclerosisBAYLOR RES INSTITUTE·Filed 2021·Granted Jan 7, 2025·1 cites·19 claims
- 0991US11267895B2Nucleic acids encoding anti-CD40 antibodiesBAYLOR RES INSTITUTE·Filed 2020·Granted Mar 8, 2022·2 cites·13 claims
- 1091US2025018025A1Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc-asgpr)BAYLOR RES INSTITUTE·Filed 2024·Application pending·0 cites
- 1190US9562104B2Anti-CD40 antibodiesBANCHEREAU JACQUES F·Filed 2010·Granted Feb 7, 2017·10 cites·20 claims
- 1290US9109011B2Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/NefBANCHEREAU JACQUES F·Filed 2009·Granted Aug 18, 2015·27 cites·5 claims
- 1390US2025121048A1Novel vaccines against hpv and hpv-related diseasesBAYLOR RES INSTITUTE·Filed 2024·Application pending·0 cites
- 1489US11717567B2Vaccines against HPV and HPV-related diseasesBAYLOR RES INSTITUTE·Filed 2021·Granted Aug 8, 2023·1 cites·22 claims
- 1589US10286058B2Vaccines against HPV and HPV-related diseasesBAYLOR RES INSTITUTE·Filed 2015·Granted May 14, 2019·6 cites·21 claims
- 1688US11173202B2Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)BAYLOR RES INSTITUTE·Filed 2019·Granted Nov 16, 2021·1 cites·10 claims
- 1788US10683361B2Anti-CD40 antibodiesBAYLOR RES INSTITUTE·Filed 2018·Granted Jun 16, 2020·2 cites·15 claims
- 1887US9339556B2Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1)BAYLOR RES INST·Filed 2013·Granted May 17, 2016·8 cites·13 claims
- 1986US8481314B2Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1)BANCHEREAU JACQUES F·Filed 2008·Granted Jul 9, 2013·8 cites·8 claims
- 2083US10087256B2Method of making an anti-CD40 antibodyBAYLOR RES INSTITUTE·Filed 2017·Granted Oct 2, 2018·2 cites·11 claims
- 2183US9315580B2Vaccines directed to langerhans cellsBAYLOR RES INST·Filed 2013·Granted Apr 19, 2016·5 cites·7 claims
- 2280US10980869B2Fusion proteins comprising an anti-CD40 antibody and cancer antigensBAYLOR RES INSTITUTE·Filed 2017·Granted Apr 20, 2021·1 cites·7 claims
- 2380US9567401B2Anti-CD40 antibodiesBAYLOR RES INST·Filed 2014·Granted Feb 14, 2017·2 cites·9 claims
- 2478US10279030B2Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)BAYLOR RES INSTITUTE·Filed 2016·Granted May 7, 2019·1 cites·6 claims
- 2578US2022340670A1Anti-cd40 antibodies and uses thereofBAYLOR RES INSTITUTE·Filed 2022·Application pending·0 cites
- 2677US8043623B2Immunogenic peptides for the treatment of prostate and breast cancerUS GOV HEALTH & HUMAN SERV·Filed 2009·Granted Oct 25, 2011·1 cites·25 claims
- 2776US9045542B2Controlling allergy and asthma by activating human DCs via Dectin-1 or toll-like receptor 2 (TLR2)OH SANGKON·Filed 2012·Granted Jun 2, 2015·6 cites·4 claims
- 2876US7541035B2Immunogenic peptides for the treatment of prostate and breast cancerUS HEALTH·Filed 2004·Granted Jun 2, 2009·4 cites·25 claims
- 2973US9061066B2Immunoadjuvant compounds and uses thereofGORVEL JEAN-PIERRE·Filed 2011·Granted Jun 23, 2015·2 cites·8 claims
- 3069US10940195B2Vaccines against HPV and HPV-related diseasesBAYLOR RES INSTITUTE·Filed 2019·Granted Mar 9, 2021·0 cites·19 claims
- 3168US2025144191A1Dendritic cell asgpr targeting immunotherapeutics for multiple sclerosisBAYLOR RES INSTITUTE·Filed 2025·Application pending·0 cites
- 3267US11957734B2Methods and compositions for treating autoimmune and inflammatory conditionsBAYLOR RES INSTITUTE·Filed 2021·Granted Apr 16, 2024·0 cites·20 claims
- 3365US10167339B2Antagonistic anti-OX40L antibodies and methods of their useBAYLOR RES INSTITUTE·Filed 2015·Granted Jan 1, 2019·1 cites·16 claims
- 3458US2016296609A1Dendritic cell asgpr targeting immunotherapeutics for multiple sclerosisBAYLOR RES INST·Filed 2014·Application pending·0 cites
- 3556US2015064205A1Enhancement of pathogen-specific memory th17 cell responsesBAYLOR RES INST·Filed 2014·Application pending·0 cites
- 3655US2008233140A1Therapeutic Applications of Activation of Human Antigen-Presenting Cells Through Dectin-1BAYLOR RES INST·Filed 2008·Application pending·0 cites
- 3754US10993990B2Methods and compositions for treating autoimmune and inflammatory conditionsBAYLOR RES INSTITUTE·Filed 2015·Granted May 4, 2021·0 cites·7 claims
- 3852US10570208B2Antagonistic anti-OX40L antibodies and methods of their useBAYLOR RES INSTITUTE·Filed 2018·Granted Feb 25, 2020·0 cites·20 claims
- 3951US2016022792A1Antigen presenting cell targeted cancer vaccinesBAYLOR RES INST·Filed 2015·Application pending·0 cites
- 4051US2014322214A1Therapeutic applications of activation of human antigen-presenting cells through dectin-1BAYLOR RES INST·Filed 2014·Application pending·0 cites
- 4150US2008254047A1Activation of Human Antigen-Presenting Cells Through CLEC-6BAYLOR RES INST·Filed 2008·Application pending·0 cites
- 4247US2013064855A1Reprogramming immune environment in breast cancer via dendritic cellsPALUCKA ANNA KAROLINA·Filed 2012·Application pending·0 cites
- 4345US2011081343A1Vaccines directed to langerhans cellsBAYLOR RES INST·Filed 2010·Application pending·0 cites
- 4443US2012128710A1Enhancement of Pathogen-Specific Memory Th17 Cell ResponsesOH SANGKON·Filed 2011·Application pending·0 cites
- 4542US2013017151A1SUBSETS OF ANTIGEN-PRESENTING CELLS (APCs) IN THE HUMAN VAGINA AND THEIR DISTINCT FUNCTIONSBAYLOR RES INST·Filed 2012·Application pending·0 cites
- 4642US2012121592A1Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-CellsOH SANGKON·Filed 2011·Application pending·0 cites
- 4741US2012308578A1SLE-DC-MEDIATED ENHANCED IgG- AND IgA-SECRETING B CELL RESPONSESOH SANGKON·Filed 2012·Application pending·0 cites
- 4835US2012213768A1Diagnostic and Therapeutic Uses for B Cell Maturation AntigenOH SANGKON·Filed 2012·Application pending·0 cites
- 4928US2017095573A1Methods and compositions for treating allergy and inflammatory diseasesBAYLOR RES INST·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sangkon Oh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →